• Home
  • About
  • Team
  • Research
  • News & Blog
  • Careers
  • Contact
  • Order
  • May
    10
    2018

    May, 2018: ImCare Biotech is invited to attend the NCI SBIR Workshop on Resources for Accelerating Commercialization

    ImCare Biotech is invited to attend the NCI SBIR Workshop on Resources for Accelerating Commercialization. The NCI SBIR Development Center offers a two-day commercialization workshop for current NCI SBIR/STTR awardees. The workshop provides awardees an opportunity to learn how to utilize federal and local resources in order to advance commercialization. The workshop brings together representatives from the FDA, CMS, and BARDA, as well as experts from local and private organizations to share their expertise with attending companies.

    ImCare Biotech Team
    Categories:
    • Company
    • News
  • Oct
    10
    2017

    October, 2017: ImCare Biotech completes the NIH CAP Program

    ImCare Biotech completes the NIH CAP Program. The National Institutes of Health (NIH) Commercialization Accelerator Program (CAP) is a nationwide program funded by NIH and managed by Larta, Inc. The goal of CAP is to assist some of the most promising small life science and healthcare companies in bringing their technologies to market.

    ImCare Biotech Team
    Categories:
    • Company
    • News
  • Apr
    18
    2015

    April 2015: ImCare Biotech has been awarded Phase II grant by NCI (NIH)

    ImCare Biotech has been awarded Phase II grant by NCI (NIH) for its project on development of a diagnostic kit for early detection of liver cancer.

    ImCare Biotech Team
    Tags:
    • detection of liver cancer
    • diagnostic kit
    • imcare biotech
    • national cancer institute
    • phase ii grant
    Categories:
    • Company
    • News
    • Product
  • Jan
    18
    2015

    January 2015: Harvard Medical School Partnership

    Imcare Biotech has entered into a development partnership with Harvard Medical School.

    ImCare Biotech Team
    Tags:
    • development partnership
    • Harvard Medical School
    • imcare biotech
    Categories:
    • Company
    • News
  • Jul
    18
    2014

    July 2014: Ohio State University Partnership

    Imcare Biotech has entered into a development partnership with Ohio State University.

    ImCare Biotech Team
    Tags:
    • development partnership
    • imcare biotech
    • Ohio State University
    Categories:
    • Company
    • News
  • Jan
    18
    2014

    January 2014: Thomas Jefferson University Partnership

    Imcare Biotech has entered into a development partnership with Thomas Jefferson University.

    ImCare Biotech Team
    Tags:
    • development partnership
    • imcare biotech
    • Thomas Jefferson University
    Categories:
    • Company
    • News
  • Aug
    18
    2013

    August 2013: Anti-SPINK1 antibody (BA1)

    ImCare has developed a new Anti-SPINK1 antibody (BA1), which recognizes native human pancreatic secreted SPINK1/TATI/PSTI in WB and ELISA. More information about this monoclonal antibody and the ELISA kit based on this monoclonal antibody, please contact info@imcarebiotech.com

    ImCare Biotech Team
    Tags:
    • anti-spink1 antibody
    • elisa
    • imcare biotech
    • psti
    • recognizes native human pancreatic secreted
    • spink1
    • tati
    Categories:
    • Company
    • News
    • Product
  • Jul
    18
    2013

    July 2013: Serine Protease Inhibitor Kazal antibodies

    USA patent application 13/991943 Serine Protease Inhibitor Kazal antibodies (Inventor: X. Lu and T. Block) has been filed.

    ImCare Biotech Team
    Tags:
    • imcare biotech
    • serine protease inhibitor kazal antibodies
    • T. Block
    • usa patent application 13/991943
    • Xuanyong Lu
    Categories:
    • Company
    • News
    • Product
  • Feb
    18
    2013

    February 2013: Immune-absorbance real time PCR (IA-PCR)

    A novel technology named Immune-absorbance real time PCR (IA-PCR) with extremely high sensitivity as PCR and great specificity as ELISA has been developed by ImCare Biotech. This technology can be used to quantify any enveloped viruses. Based on this technology, a high-throughput screening system has been established by ImCare Biotech and is successfully used to identify anti-viral drugs.

    ImCare Biotech Team
    Tags:
    • identify anti viral drugs
    • imcare biotech
    • immune absorbance real time
    • quantify enveloped viruses
    • technology
    Categories:
    • Company
    • News
    • Product
  • 1
  • 2
Post Categories
NEWS
BLOG
COMPANY
PRODUCT
Archives
  • 2025
  • 2024
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
Address
  • 3805 Old Easton Road, Doylestown, PA 18902, USA
  • (+1) 215-489-4906
  • info@imcarebiotech.com
  • https://www.imcarebiotech.com

© 2025 ImCare Biotech, Inc. All Rights Reserved | Privacy Policy